GLP-1R agonists notably reduce retinal inflammation, suppress reactive oxygen species, and maintain the blood/retina barrier
Important Notes This is a live, interactive event
Personalized Treatment Approaches While these new medications represent a significant leap forward in obesity treatment, theyre not a one-size-fits-all solution
Much like an ill-timed phone call from Granny, 2020 has really dampened the fire in our loins
It is typically prescribed to adults who are either obese or overweight and have a related health condition, such as increased cholesterol, type 2 diabetes, or high blood pressure levels
It is recommended to shake before use